Literature DB >> 31230827

Prevalence and burden of asthma in China: time to act.

Guy G Brusselle1, Fanny Wai-San Ko2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31230827     DOI： 10.1016/S0140-6736(19)31349-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Long-Term Trends of Asthma Mortality in China from 2000 to 2019: A Joinpoint Regression and Age-Period-Cohort Analysis.

Authors:  Guimin Huang; Junting Liu; Tao Li; Dongqing Hou; Wenqian Liu; Yixuan Xie; Tong Zhang; Yijing Cheng
Journal:  Healthcare (Basel)       Date:  2022-02-11

2.  Trends and age-period-cohort effects on incidence and mortality of asthma in Sichuan Province, China, 1990-2019.

Authors:  Yu Luo; Mu Wang; Yumei Tian
Journal:  BMC Pulm Med       Date:  2022-08-03       Impact factor: 3.320

3.  Visualizing the knowledge domains and research trends of childhood asthma: A scientometric analysis with CiteSpace.

Authors:  Jinghua Wu; Yi Yu; Xinmeng Yao; Qinzhun Zhang; Qin Zhou; Weihong Tang; Xianglong Huang; Chengyin Ye
Journal:  Front Pediatr       Date:  2022-09-30       Impact factor: 3.569

4.  Optimizing inhalation therapy in the aspect of peak inhalation flow rate in patients with chronic obstructive pulmonary disease or asthma.

Authors:  Jian-Lan Hua; Xiao-Fen Ye; Chun-Ling Du; Ning Xie; Jie-Qing Zhang; Man Li; Jing Zhang
Journal:  BMC Pulm Med       Date:  2021-09-24       Impact factor: 3.317

5.  Investigation of the Mechanisms of Chuankezhi Injection in the Treatment of Asthma Based on the Network Pharmacology Approach.

Authors:  Hao Zhu; Yuhuan Shi; Shanshan Jiang; Xiuxiu Jiao; Hui Zhu; Rong Wang; Yongfang Yuan
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-10       Impact factor: 2.629
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.